Clinical Safety and Efficacy of Hyaluronic Acid–Niacinamide–Tranexamic Acid Injectable Hydrogel for Multifactorial Facial Skin Quality Enhancement with Dark Skin Lightening
Gels · 26.06.2025 · 11 (7) · 495
DOI: 10.3390/gels11070495 ↗Kurz gefasst
Fachartikel in der Zeitschrift Gels, online erschienen am 26.06.2025. Verfasst von Sarah Hsin und 8 weiteren Autor:innen. Beteiligte Einrichtung: Development Department, LOUNA REGENERATIVE SA, CH-1207 Geneva, Switzerland. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 83 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Facial aging is a complex process manifesting as skin hyperpigmentation, textural irregularities, and a diminished elasticity, hydration, and evenness of tone. The escalating demand for minimally invasive aesthetic interventions has driven the development of advanced hydrogel-based injectable formulations. This clinical study assessed the safety and efficacy of Hydragel A1, an injectable hydrogel containing hyaluronic acid (HA), niacinamide, and tranexamic acid (TXA), designed to simultaneously address multiple facets of facial skin aging. A cohort of 49 female participants underwent a series of objective and subjective assessments, including the Global Aesthetic Improvement Scale (GAIS), instrumental measurements (Antera 3D, Chromameter, Cutometer, Dermascan, Corneometer), and standardized photographic documentation at baseline (Day 0) and 14, 28, and 70 days post-treatment. The results demonstrated statistically significant improvements in skin hydration, texture, elasticity, and pigmentation following Hydragel A1 administration. Notably, no serious adverse events or significant injection site reactions were observed, confirming the favorable safety profile of the investigated device. Collectively, these findings underscore the potential of a combined HA, niacinamide, and TXA injectable formulation to provide a comprehensive approach to facial skin rejuvenation, effectively targeting multiple aging-related mechanisms.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Development Department, LOUNA REGENERATIVE SA, CH-1207 Geneva, Switzerland.
- Plastic and Aesthetic Surgery Service, Centre Médical Lausanne Ouest, CH-1008 Prilly, Switzerland.
- Plastic and Reconstructive Surgery, Ensemble Hospitalier de la Côte, CH-1110 Morges, Switzerland.
- Aesthetic Surgery Department, Clinique Entourage, CH-1003 Lausanne, Switzerland.
- Regenerative Therapy Unit, Lausanne University Hospital, University of Lausanne, CH-1066 Epalinges, Switzerland.
- Center for Applied Biotechnology and Molecular Medicine, University of Zurich, CH-8057 Zurich, Switzerland.
ORCID-Profile: Alexandre Porcello, Wassim Raffoul, Marco Cerrano, Lee Ann Applegate, Alexis E Laurent
Zitieren
APA
Hsin, S., Lourenço, K., Porcello, A., Chemali, M., Marques, C., Raffoul, W., Cerrano, M., Applegate, L. A., & Laurent, A. E. (2025). Clinical Safety and Efficacy of Hyaluronic Acid–Niacinamide–Tranexamic Acid Injectable Hydrogel for Multifactorial Facial Skin Quality Enhancement with Dark Skin Lightening. Gels, 11(7), 495. https://doi.org/10.3390/gels11070495
Vancouver
Hsin S, Lourenço K, Porcello A, Chemali M, Marques C, Raffoul W, et al. Clinical Safety and Efficacy of Hyaluronic Acid–Niacinamide–Tranexamic Acid Injectable Hydrogel for Multifactorial Facial Skin Quality Enhancement with Dark Skin Lightening. Gels. 2025;11(7):495. doi:10.3390/gels11070495
BibTeX
@article{Hsin2025,
author = {Hsin, Sarah and Lourenço, Kelly and Porcello, Alexandre and Chemali, Michèle and Marques, Cíntia and Raffoul, Wassim and Cerrano, Marco and Applegate, Lee Ann and Laurent, Alexis E},
title = {Clinical Safety and Efficacy of Hyaluronic Acid–Niacinamide–Tranexamic Acid Injectable Hydrogel for Multifactorial Facial Skin Quality Enhancement with Dark Skin Lightening},
journal = {Gels},
year = {2025},
volume = {11},
number = {7},
pages = {495},
doi = {10.3390/gels11070495}
}
EUVIMED